Individuals with a germline CEBPA N-terminal mutation at AML diagnosis, often acquire C-terminal CEBPA mutations within the bZIP region (predominantly missense or in-frame indels), highlighting the synergistic effect of these lesions and their selection during clonal expansion (69). This evidence concerns the gene CEBPA and acute myeloid leukemia.